India  
 
NewsR.in

Vaccine shortage due to India supply delay and need to retest batches – Hancock

Video Credit: PA - Press Association STUDIO - Duration: 01:24s - Published
Vaccine shortage due to India supply delay and need to retest batches – Hancock

Vaccine shortage due to India supply delay and need to retest batches – Hancock

A delay in deliveries from India and the need to retest a batch of 1.7 million doses is behind an expected shortfall in coronavirus vaccine supply in April, Matt Hancock has said.The Health Secretary told MPs that a partnership with the Serum Institute of India is one the UK “can be proud of”, despite a delay in deliveries of the AstraZeneca vaccine from its plant.


You Might Like


💡 newsR Knowledge: Other News Mentions

AstraZeneca AstraZeneca British pharmaceutical company

AstraZeneca pulls its COVID-19 vaccine from the European market [Video]

AstraZeneca pulls its COVID-19 vaccine from the European market

Credit: FRANCE 24 English    Duration: 01:37Published

Stopped producing Covishield in Dec 2021: SII after AstraZeneca recall

 UK-based drug major AstraZeneca's decision to withdraw its Covid-19 vaccine globally, days after admitting to side effects, prompted Serum Institute of India to..
IndiaTimes
AstraZeneca requests European authorisation of Covid vaccine be pulled [Video]

AstraZeneca requests European authorisation of Covid vaccine be pulled

AstraZeneca was the first pharmaceutical laboratory to launch a vaccine on the market at the end of 2020, a year after the appearance of the virus.

Credit: euronews (in English)    Duration: 00:35Published

SII stopped manufacturing Covishield since December 2021, says 'disclosed side effects details in packaging insert'

 SII stopped Covishield extra doses due to lawsuit, disclosed rare Thrombosis. Advocates govt collaboration. AstraZeneca withdraws Vaxzevria marketing..
IndiaTimes

AstraZeneca starts worldwide withdrawal of COVID vaccine

 AstraZeneca has begun the worldwide withdrawal of its COVID vaccine - ending an era in which it saved millions of lives while being dogged by controversy.
Sky News

Serum Institute of India Serum Institute of India Indian biotechnology and biopharmaceuticals company


Related videos from verified sources

Hancock: UK supply of Covid vaccines delayed [Video]

Hancock: UK supply of Covid vaccines delayed

Matt Hancock says the UK is still on track to meet its vaccination target despite supply chain issues. Speaking in the House of Commons, the Health Secretary said a batch of 1.7m doses has been delayed..

Credit: ODN     Duration: 01:00Published